Autres langues Hologic, Inc.

Actions

HOLX

US4364401012

Temps réel estimé Cboe BZX Autres places de cotation 18:57:06 30/04/2024			Varia. 5j.	Varia. 1 janv.
76,03 ^USD	-0,78 %		-1,63 %	+6,27 %

15:18	La société de portefeuille de Molten Ventures est rachetée par Hologic	AN
12:56	La société de portefeuille de Molten Ventures rachète Endomagnetics pour 310 millions USD	AN

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Molten Ventures portfolio firm gets bought by Hologic	15:18
Molten Ventures portfolio firm to buy Endomagnetics for USD310 million	12:56
Hologic to Acquire Breast Cancer Surgery Technology Firm Endomagnetics For $310 Million	29/04
Hologic to Acquire Endomagnetics Ltd, a Breast Surgical Guidance Company	29/04
Hologic, Inc. signed a definitive agreement to acquire Endomagnetics Ltd. for approximately $310 million.	29/04
Hologic : Receives Innovative Technology Contract From Vizient for CoolSeal® Advanced Energy Portfolio and JustRight® 5 mm Stapler	16/04
Bayer and Hologic Collaborates to Deliver Contrast-Enhanced Mammography	11/04
Hologic : to present at Needham Virtual Healthcare Conference Transcript	10/04
North American Morning Briefing : Focus Turns to -2-	04/04
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2024 on Thursday, May 2, 2024	02/04
Maverix Medical Closes Acquisition of Cirrus Bio as Foundation for Diagnostics Platform in Lung Cancer	01/04
Watching for Indications of a Changed Fed Outlook; Plus, How One Company Avoided Mass Layoffs	20/03
Hologic Insider Sold Shares Worth $1,241,296, According to a Recent SEC Filing	15/03
Hologic : Annual Meeting of Stockholders Proxy	07/03
Hologic, Inc. - Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be Over or Undertreated Without Breast Cancer Index Genomic Testing	06/03
Hologic : to present at Raymond James' 45th Annual Institutional Investors Conference Transcript	06/03
Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be Over- or Undertreated Without Breast Cancer Index Genomic Testing	05/03
Hologic, Inc. and Biotheranostics, Inc. Announces Newly Published Study Results Reveal That Use of the Breast Cancer Index®? Test	05/03
FDA warns of potential risk from Hologic's devices implanted in soft tissue	27/02
FDA warns of potential risk of complications with use of Hologic's devices	27/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Hologic, Inc.

Actions

HOLX

US4364401012

Autres langues

Filtres